Get started
DIAMYD MEDICAL ABDIAMYD MEDICAL ABDIAMYD MEDICAL AB

DIAMYD MEDICAL AB

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonalsETFs

Chart


Full chart

Key stats


Market capitalization
‪260.86 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1607 USD
Net income (FY)
‪−17.88 M‬ USD
Revenue (FY)
‪13.69 K‬ USD
Shares float
‪118.70 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
39
Change (1Y)
+11 +39.29%
Revenue / Employee (1Y)
351.00 USD
Net income / Employee (1Y)
‪−458.40 K‬ USD

About Diamyd Medical AB Class B


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ulf Hannelius
Website
diamyd.com
Headquarters
Stockholm
Founded
1984
IPO date
May 20, 2013
Identifiers
2
ISIN SE0005162880
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen, which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. The company also develops and invests in stem cell and medical technology. Diamyd Medical was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

Check out other big names from the same industry as DYMDF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


ISCF
iShares International Small-Cap Equity Factor ETF
Weight
0.02%
Market value
‪104.44 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of DYMDF is 0.7300 USD — it has decreased by −57.06% in the past 24 hours. Watch DIAMYD MEDICAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange DIAMYD MEDICAL AB stocks are traded under the ticker DYMDF.
DYMDF reached its all-time high on Jun 7, 2021 with the price of 3.8729 USD, and its all-time low was 0.7300 USD and was reached on Apr 14, 2025. View more price dynamics on DYMDF chart.
See other stocks reaching their highest and lowest prices.
DYMDF stock is 132.88% volatile and has beta coefficient of 1.05. Track DIAMYD MEDICAL AB stock price on the chart and check out the list of the most volatile stocks — is DIAMYD MEDICAL AB there?
Today DIAMYD MEDICAL AB has the market capitalization of ‪260.87 M‬, it has increased by 19.86% over the last week.
Yes, you can track DIAMYD MEDICAL AB financials in yearly and quarterly reports right on TradingView.
DYMDF net income for the last quarter is ‪−5.15 M‬ USD, while the quarter before that showed ‪−4.72 M‬ USD of net income which accounts for −8.97% change. Track more DIAMYD MEDICAL AB financial stats to get the full picture.
No, DYMDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 39 employees. See our rating of the largest employees — is DIAMYD MEDICAL AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMYD MEDICAL AB EBITDA is ‪−19.60 M‬ USD, and current EBITDA margin is ‪−138.28 K‬%. See more stats in DIAMYD MEDICAL AB financial statements.
Like other stocks, DYMDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMYD MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.